Literature DB >> 16276149

A histologic study of adverse effects of different cosmetic skin fillers.

Meire B Parada1, Nílceo S Michalany, Karime M Hassun, Ediléia Bagatin, Sérgio Talarico.   

Abstract

OBJECTIVE: This study was designed to describe the histologic aspects of the cutaneous and mucosal adverse reactions to fillers used for cosmetic purposes. METHODS AND MATERIALS: Eleven specimens of adverse reactions caused by Restylane, Artecoll, Metacril, New-Fill, Aquamid, and liquid silicone were processed and stained by hematoxylin-eosin and Alcian blue and submitted to polarized light.
RESULTS: Most of the reactions were foreign-body granulomas.
CONCLUSIONS: The type of granuloma and the characteristics of the agent were determined, contributing to the histologic identification of the material used. In the cases involving Restylane and Aquamid, it was possible to identify the material using Alcian blue stain and by the presence of necrosis. This stain was strongly positive in Restylane and faintly positive in Aquamid, and intense necrosis was observed in Aquamid cases. In the other cases the filler material itself was recognized and identified.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16276149     DOI: 10.1111/j.1540-9740.2005.04061.x

Source DB:  PubMed          Journal:  Skinmed        ISSN: 1540-9740


  2 in total

Review 1.  A case series and a review of the literature on foreign modelling agent reaction: an emerging problem.

Authors:  Ashley A Martínez-Villarreal; Daniel Asz-Sigall; Daniela Gutiérrez-Mendoza; Thomas E Serena; Adriana Lozano-Platonoff; Lourdes Y Sanchez-Cruz; Sonia Toussaint-Caire; Judith Domínguez-Cherit; Lirio A López-García; Andrea Cárdenas-Sánchez; José Contreras-Ruiz
Journal:  Int Wound J       Date:  2016-08-04       Impact factor: 3.315

Review 2.  Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers.

Authors:  Paul C Edwards; John E Fantasia
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.